sebsebseb personal page - To The Moon

sebsebseb

sebsebseb

No personal profile

22Follow

2Followers

0Topic

0Badge

2021-06-24

Grow

Sorry, the original content has been removed

2021-06-24

Move

Sorry, the original content has been removed

2021-06-24

Upppp

OCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed

2021-06-24

Up

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN

2021-06-24

Fly

Sorry, the original content has been removed

2021-06-23

Up

Sorry, the original content has been removed

2021-06-23

Up

Sorry, the original content has been removed

2021-06-22

Buyy

5 Ultra-Popular Stocks Wall Street Views as Overvalued

2021-06-22

Discount

BRIEF-Gamestop Corp Says Matthew Furlong To Not Receive Additional Compensation For His Service As Board Member

2021-06-21

Hi

Sorry, the original content has been removed

2021-06-21

Hi

Sorry, the original content has been removed

2021-06-20

Gi

Sorry, the original content has been removed

2021-06-20

Hi

Sorry, the original content has been removed

2021-06-19

Hi

The U.S. Treasury Calls for Crypto Transfers Over $10,000 Reported to IRS

2021-06-19

Hi

Sorry, the original content has been removed

2021-06-18

Hmmm

Virgin Galactic Holdings, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

2021-06-18

Sold too early

The Opportunity In XPeng Inc. (NYSE:XPEV) And The Risks From The Big Picture

2021-06-18

Crazy news

Sorry, the original content has been removed

2021-06-17

Great

Sorry, the original content has been removed

2021-06-17

Is that truw

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3575086147705955,"uuid":"3575086147705955","gmtCreate":1611992124051,"gmtModify":1613789947788,"name":"sebsebseb","pinyin":"sebsebseb","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":22,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.87%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":128468610,"gmtCreate":1624528013230,"gmtModify":1703839413460,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grow","listText":"Grow","text":"Grow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128468610","repostId":"2140464395","repostType":2,"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128468913,"gmtCreate":1624527993332,"gmtModify":1703839413298,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Move","listText":"Move","text":"Move","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128468913","repostId":"2145664057","repostType":2,"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121517418,"gmtCreate":1624475324134,"gmtModify":1703837836844,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Upppp","listText":"Upppp","text":"Upppp","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121517418","repostId":"2145768039","repostType":2,"repost":{"id":"2145768039","pubTimestamp":1624305600,"share":"https://www.laohu8.com/m/news/2145768039?lang=&edition=full","pubTime":"2021-06-22 04:00","market":"us","language":"en","title":"OCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed","url":"https://stock-news.laohu8.com/highlight/detail?id=2145768039","media":"ACCESSWIRE","summary":"BOSTON, MA / ACCESSWIRE / June 21, 2021 / The Thornton Law Firm alerts investors that a class action","content":"<html><body><p><strong>BOSTON, MA / ACCESSWIRE / June 21, 2021 /</strong> The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Ocugen, Inc. (NASDAQ:OCGN). The case is currently in the lead plaintiff stage. Investors who purchased OCGN stock or other securities between February 2, 2021 and June 10, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Ocugen for more information. Investors may also email investors@tenlaw.com or call 617-531-3917.</p>\n<img src=\"https://s1.yimg.com/uu/api/res/1.2/mqLJ.C9W9pFLvf715OGSmw--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/accesswire.ca/c7a3b2e0d9f1a11cd6634341bda24637\"/>\n<p>FOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen</p>\n<p>The case alleges that Ocugen and its senior executives made misleading statements to investors and failed to disclose that: (i) the information that Ocugen submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"); and (ii) Ocugen would not file an EUA with the FDA.</p>\n<p>Interested Ocugen investors have until August 17, 2021 to retain counsel and apply to be a lead plaintiff if they are interested to do so. A lead plaintiff acts on behalf of all other investor class members in managing the class action. Investors do not need to be a lead plaintiff in order to be a class member. If investors choose to take no action, they can remain an absent class member. The class has not yet been certified. Until certification occurs, investors are not represented by an attorney. Thornton Law Firm is not currently representing a plaintiff who filed a complaint but is investigating the case on behalf of investors interested in being a lead plaintiff.</p>\n<p>FOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen</p>\n<p>Thornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.</p>\n<p><strong>CONTACT:</strong><br/>Thornton Law Firm LLP<br/>1 Lincoln Street<br/>State Street Financial Center<br/>Boston, MA 02111</p>\n<p>www.tenlaw.com/cases/Ocugen</p>\n<p><strong>SOURCE: </strong>Thornton Law Firm LLP</p>\n<br/>\n<br/>View source version on accesswire.com: \n<br/>\nhttps://www.accesswire.com/652560/OCUGEN-INVESTOR-ALERT-Shareholder-Lawsuit-Filed\n<br/>\n<br/>\n<img height=\"0\" src=\"https://www.accesswire.com/img.ashx?id=652560\" width=\"0\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 04:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ocugen-investor-alert-shareholder-lawsuit-200000687.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BOSTON, MA / ACCESSWIRE / June 21, 2021 / The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Ocugen, Inc. (NASDAQ:OCGN). The case is currently ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ocugen-investor-alert-shareholder-lawsuit-200000687.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/rV.SVOf.fSvuCtY32DMuZw--~B/aD03ODt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Ou0Q5rJmDqIAq0wjQnhE3A--~B/aD03ODt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/accesswire.ca/c7a3b2e0d9f1a11cd6634341bda24637","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://finance.yahoo.com/news/ocugen-investor-alert-shareholder-lawsuit-200000687.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145768039","content_text":"BOSTON, MA / ACCESSWIRE / June 21, 2021 / The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Ocugen, Inc. (NASDAQ:OCGN). The case is currently in the lead plaintiff stage. Investors who purchased OCGN stock or other securities between February 2, 2021 and June 10, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Ocugen for more information. Investors may also email investors@tenlaw.com or call 617-531-3917.\n\nFOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen\nThe case alleges that Ocugen and its senior executives made misleading statements to investors and failed to disclose that: (i) the information that Ocugen submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"); and (ii) Ocugen would not file an EUA with the FDA.\nInterested Ocugen investors have until August 17, 2021 to retain counsel and apply to be a lead plaintiff if they are interested to do so. A lead plaintiff acts on behalf of all other investor class members in managing the class action. Investors do not need to be a lead plaintiff in order to be a class member. If investors choose to take no action, they can remain an absent class member. The class has not yet been certified. Until certification occurs, investors are not represented by an attorney. Thornton Law Firm is not currently representing a plaintiff who filed a complaint but is investigating the case on behalf of investors interested in being a lead plaintiff.\nFOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen\nThornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.\nCONTACT:Thornton Law Firm LLP1 Lincoln StreetState Street Financial CenterBoston, MA 02111\nwww.tenlaw.com/cases/Ocugen\nSOURCE: Thornton Law Firm LLP\n\nView source version on accesswire.com: \n\nhttps://www.accesswire.com/652560/OCUGEN-INVESTOR-ALERT-Shareholder-Lawsuit-Filed","news_type":1},"isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121517556,"gmtCreate":1624475300175,"gmtModify":1703837836682,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121517556","repostId":"2145301867","repostType":2,"repost":{"id":"2145301867","pubTimestamp":1624463100,"share":"https://www.laohu8.com/m/news/2145301867?lang=&edition=full","pubTime":"2021-06-23 23:45","market":"us","language":"en","title":"The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN","url":"https://stock-news.laohu8.com/highlight/detail?id=2145301867","media":"ACCESSWIRE","summary":"NEW YORK, NY / ACCESSWIRE / June 23, 2021 / The securities litigation law firm of The Gross Law Firm","content":"<html><body><p><strong>NEW YORK, NY / ACCESSWIRE / June 23, 2021 /</strong> The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.</p>\n<p><strong><a href=\"https://laohu8.com/S/CCIV\">Churchill Capital Corp IV</a> (NYSE:CCIV)</strong></p>\n<p><strong>Investors Affected : January 11, 2021 - February 22, 2021</strong></p>\n<p>A class action has commenced on behalf of certain shareholders in <a href=\"https://laohu8.com/S/CCIV.U\">Churchill Capital Corp IV</a>. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.</p>\n<p>Shareholders may find more information at https://securitiesclasslaw.com/securities/churchill-capital-corp-iv-loss-submission-form/?id=17122&amp;from=1</p>\n<p><strong><a href=\"https://laohu8.com/S/FREQ\">Frequency Therapeutics, Inc.</a> (NASDAQ:FREQ)</strong></p>\n<p><strong>Investors Affected : November 16, 2020 - March 22, 2021</strong></p>\n<p>A class action has commenced on behalf of certain shareholders in Frequency Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.</p>\n<p>Shareholders may find more information at https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17122&amp;from=1</p>\n<p><strong>Ocugen, Inc. (NASDAQ:OCGN)</strong></p>\n<p><strong>Investors Affected : February 2, 2021 - June 10, 2021</strong></p>\n<p>A class action has commenced on behalf of certain shareholders in Ocugen, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.</p>\n<p>Shareholders may find more information at https://securitiesclasslaw.com/securities/ocugen-inc-loss-submission-form/?id=17122&amp;from=1</p>\n<img src=\"https://s1.yimg.com/uu/api/res/1.2/DkCIlqsg_59barbKGDUmCA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/accesswire.ca/f6be8399165579e8bdfa12794c467eb2\"/>\n<p>The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.</p>\n<p><strong>CONTACT:</strong><br/>The Gross Law Firm<br/>15 West 38th Street, 12th floor<br/>New York, NY, 10018<br/>Email: dg@securitiesclasslaw.com<br/>Phone: (212) 537-9430<br/>Fax: (833) 862-7770</p>\n<p><strong>SOURCE: </strong>The Gross Law Firm</p>\n<br/>\n<br/>View source version on accesswire.com: \n<br/>\nhttps://www.accesswire.com/652845/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-FREQ-and-OCGN\n<br/>\n<br/>\n<img height=\"0\" src=\"https://www.accesswire.com/img.ashx?id=652845\" width=\"0\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 23:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/gross-law-firm-announces-class-154500273.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, NY / ACCESSWIRE / June 23, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gross-law-firm-announces-class-154500273.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/lbmg.m0FIEdY8ggrXpil3A--~B/aD0zMDc7dz0zMDc7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Cz__YWM.PoHWdcBBOe1T7g--~B/aD0zMDc7dz0zMDc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/f6be8399165579e8bdfa12794c467eb2","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://finance.yahoo.com/news/gross-law-firm-announces-class-154500273.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145301867","content_text":"NEW YORK, NY / ACCESSWIRE / June 23, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.\nChurchill Capital Corp IV (NYSE:CCIV)\nInvestors Affected : January 11, 2021 - February 22, 2021\nA class action has commenced on behalf of certain shareholders in Churchill Capital Corp IV. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.\nShareholders may find more information at https://securitiesclasslaw.com/securities/churchill-capital-corp-iv-loss-submission-form/?id=17122&from=1\nFrequency Therapeutics, Inc. (NASDAQ:FREQ)\nInvestors Affected : November 16, 2020 - March 22, 2021\nA class action has commenced on behalf of certain shareholders in Frequency Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.\nShareholders may find more information at https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17122&from=1\nOcugen, Inc. (NASDAQ:OCGN)\nInvestors Affected : February 2, 2021 - June 10, 2021\nA class action has commenced on behalf of certain shareholders in Ocugen, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.\nShareholders may find more information at https://securitiesclasslaw.com/securities/ocugen-inc-loss-submission-form/?id=17122&from=1\n\nThe Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.\nCONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@securitiesclasslaw.comPhone: (212) 537-9430Fax: (833) 862-7770\nSOURCE: The Gross Law Firm\n\nView source version on accesswire.com: \n\nhttps://www.accesswire.com/652845/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-FREQ-and-OCGN","news_type":1},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121294922,"gmtCreate":1624464516566,"gmtModify":1703837666624,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Fly","listText":"Fly","text":"Fly","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/121294922","repostId":"1181966550","repostType":2,"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123680907,"gmtCreate":1624420632909,"gmtModify":1703836140254,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/123680907","repostId":"2145050065","repostType":2,"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123680032,"gmtCreate":1624420613026,"gmtModify":1703836140579,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/123680032","repostId":"2140464395","repostType":2,"isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120326803,"gmtCreate":1624303348102,"gmtModify":1703832930486,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Buyy","listText":"Buyy","text":"Buyy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120326803","repostId":"2145084835","repostType":2,"repost":{"id":"2145084835","pubTimestamp":1624280460,"share":"https://www.laohu8.com/m/news/2145084835?lang=&edition=full","pubTime":"2021-06-21 21:01","market":"us","language":"en","title":"5 Ultra-Popular Stocks Wall Street Views as Overvalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2145084835","media":"Motley Fool","summary":"If analysts are correct, these high-flying stocks will fizzle out over the next year.","content":"<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark <b>S&amp;P 500</b> since 1980, including dividends, is north of 11%.</p>\n<p>Not surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to <b>FactSet</b>, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.</p>\n<p>Based on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.</p>\n<p><img src=\"https://static.tigerbbs.com/b04ade705354c4825038c4dfcd0187d9\" tg-width=\"700\" tg-height=\"500\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Palantir Technologies: Implied downside of 12%</h3>\n<p>Since its direct listing in late September 2020, data-mining company <b>Palantir Technologies</b> (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's <a href=\"https://laohu8.com/S/AONE\">one</a>-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.</p>\n<p>The likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.</p>\n<p>Another possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.</p>\n<p>Over the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.</p>\n<p><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Moderna: Implied downside of 11%</h3>\n<p>Biotech stock <b>Moderna</b> (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.</p>\n<p>Why the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.</p>\n<p>The other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.</p>\n<p>Based solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.</p>\n<p><img src=\"https://static.tigerbbs.com/07841e6a8173146a0fbfddf95a0f1ccb\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>GameStop: Implied downside of 71%</h3>\n<p>This will probably come as a shock to no one, but Reddit favorite <b>GameStop</b> (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it <i>still</i> implies up to 71% downside over the next year.</p>\n<p>The biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.</p>\n<p>Although the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.</p>\n<p>With sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.</p>\n<p><img src=\"https://static.tigerbbs.com/c7ff785aa0040a5565d474390f58b47a\" tg-width=\"700\" tg-height=\"457\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Ocugen: Implied downside of 18%</h3>\n<p>Volatile clinical-stage biotech stock <b>Ocugen</b> (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.</p>\n<p>Arguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.</p>\n<p>What's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.</p>\n<p>Though it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.</p>\n<p><img src=\"https://static.tigerbbs.com/91f6037829ea3fb0ae1cae0b95d8d11e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>NVIDIA: Implied downside of 3%</h3>\n<p>Don't adjust your computer, laptop, or smartphone screens -- that really says <b>NVIDIA</b> (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.</p>\n<p>One reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.</p>\n<p>Perhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.</p>\n<p>For what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks Wall Street Views as Overvalued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks Wall Street Views as Overvalued\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 21:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","PLTR":"Palantir Technologies Inc.","GME":"游戏驿站","OCGN":"Ocugen","MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145084835","content_text":"Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark S&P 500 since 1980, including dividends, is north of 11%.\nNot surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to FactSet, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.\nBased on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.\n\nImage source: Getty Images.\nPalantir Technologies: Implied downside of 12%\nSince its direct listing in late September 2020, data-mining company Palantir Technologies (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's one-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.\nThe likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.\nAnother possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.\nOver the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.\n\nImage source: Getty Images.\nModerna: Implied downside of 11%\nBiotech stock Moderna (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's one of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.\nWhy the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.\nThe other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.\nBased solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.\n\nImage source: Getty Images.\nGameStop: Implied downside of 71%\nThis will probably come as a shock to no one, but Reddit favorite GameStop (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it still implies up to 71% downside over the next year.\nThe biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.\nAlthough the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.\nWith sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.\n\nImage source: Getty Images.\nOcugen: Implied downside of 18%\nVolatile clinical-stage biotech stock Ocugen (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.\nArguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.\nWhat's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.\nThough it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.\n\nImage source: Getty Images.\nNVIDIA: Implied downside of 3%\nDon't adjust your computer, laptop, or smartphone screens -- that really says NVIDIA (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.\nOne reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.\nPerhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.\nFor what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.","news_type":1},"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120326108,"gmtCreate":1624303335604,"gmtModify":1703832930164,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Discount","listText":"Discount","text":"Discount","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120326108","repostId":"2145103320","repostType":2,"repost":{"id":"2145103320","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624287173,"share":"https://www.laohu8.com/m/news/2145103320?lang=&edition=full","pubTime":"2021-06-21 22:52","market":"us","language":"en","title":"BRIEF-Gamestop Corp Says Matthew Furlong To Not Receive Additional Compensation For His Service As Board Member","url":"https://stock-news.laohu8.com/highlight/detail?id=2145103320","media":"Reuters","summary":"June 21 (Reuters) - GameStop Corp   :   * GAMESTOP CORP - MATTHEW FURLONG WILL NOT RECEIVE ADDITIONA","content":"<html><body><p>June 21 (Reuters) - GameStop Corp   :</p><p>   * <a href=\"https://laohu8.com/S/0A6L.UK\">GAMESTOP CORP</a> - MATTHEW FURLONG WILL NOT RECEIVE ADDITIONAL COMPENSATION FOR HIS SERVICE AS A MEMBER OF BOARD</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Gamestop Corp Says Matthew Furlong To Not Receive Additional Compensation For His Service As Board Member</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Gamestop Corp Says Matthew Furlong To Not Receive Additional Compensation For His Service As Board Member\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-21 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 21 (Reuters) - GameStop Corp   :</p><p>   * <a href=\"https://laohu8.com/S/0A6L.UK\">GAMESTOP CORP</a> - MATTHEW FURLONG WILL NOT RECEIVE ADDITIONAL COMPENSATION FOR HIS SERVICE AS A MEMBER OF BOARD</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","SCI":"Service Corp International"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145103320","content_text":"June 21 (Reuters) - GameStop Corp   :   * GAMESTOP CORP - MATTHEW FURLONG WILL NOT RECEIVE ADDITIONAL COMPENSATION FOR HIS SERVICE AS A MEMBER OF BOARD Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164598972,"gmtCreate":1624226768796,"gmtModify":1703830762751,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164598972","repostId":"2140461107","repostType":2,"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164591716,"gmtCreate":1624226754335,"gmtModify":1703830765690,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164591716","repostId":"2140464395","repostType":2,"isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165773898,"gmtCreate":1624159480214,"gmtModify":1703829779509,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Gi","listText":"Gi","text":"Gi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165773898","repostId":"2134569564","repostType":2,"isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165779770,"gmtCreate":1624159466490,"gmtModify":1703829779026,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165779770","repostId":"2127383008","repostType":2,"isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162130288,"gmtCreate":1624039470944,"gmtModify":1703827463880,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162130288","repostId":"1135487235","repostType":2,"repost":{"id":"1135487235","pubTimestamp":1621527633,"share":"https://www.laohu8.com/m/news/1135487235?lang=&edition=full","pubTime":"2021-05-21 00:20","market":"us","language":"en","title":"The U.S. Treasury Calls for Crypto Transfers Over $10,000 Reported to IRS","url":"https://stock-news.laohu8.com/highlight/detail?id=1135487235","media":"Bloomberg","summary":"Proposal included in report on Biden IRS enforcement planAdministration says tighter enforcement to ","content":"<ul><li>Proposal included in report on Biden IRS enforcement plan</li><li>Administration says tighter enforcement to boost tax revenue</li></ul><p>The U.S. Treasury said the Biden administration’s proposal to strengthen tax compliance includes a requirement for transfers of at least $10,000 of cryptocurrency to be reported to the Internal Revenue Service.</p><p>“As with cash transactions, businesses that receive cryptoassets with a fair-market value of more than $10,000 would also be reported on,” the Treasury Department said in a report on tax-enforcement proposals released Thursday.</p><p>The Treasury said that comprehensive reporting is necessary “to minimize the incentives and opportunity to shift income out of the new information reporting regime.” Itnotedthat cryptocurrency is a small share of current business transactions.</p><p>The IRS in 2020 added a line about cryptocurrency on the Form 1040, the individual tax return, in an effort to gain more visibility into virtual currency transactions.</p><p>President Joe Biden’s administration is also calling for banks to report on account flows to help boost tax-payment compliance.</p><p>“Cryptocurrency already poses a significant detection problem by facilitating illegal activity broadly including tax evasion,” the Treasury said.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The U.S. Treasury Calls for Crypto Transfers Over $10,000 Reported to IRS</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe U.S. Treasury Calls for Crypto Transfers Over $10,000 Reported to IRS\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-21 00:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-05-20/treasury-calls-for-crypto-transfers-over-10-000-reported-to-irs?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Proposal included in report on Biden IRS enforcement planAdministration says tighter enforcement to boost tax revenueThe U.S. Treasury said the Biden administration’s proposal to strengthen tax ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-05-20/treasury-calls-for-crypto-transfers-over-10-000-reported-to-irs?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAN":"嘉楠科技","PYPL":"PayPal","COIN":"Coinbase Global, Inc.","TSLA":"特斯拉",".DJI":"道琼斯","SQ":"Block","BTBT":"Bit Digital, Inc.",".IXIC":"NASDAQ Composite","GBTC":"Grayscale Bitcoin Trust","MARA":"Marathon Digital Holdings Inc",".SPX":"S&P 500 Index"},"source_url":"https://www.bloomberg.com/news/articles/2021-05-20/treasury-calls-for-crypto-transfers-over-10-000-reported-to-irs?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135487235","content_text":"Proposal included in report on Biden IRS enforcement planAdministration says tighter enforcement to boost tax revenueThe U.S. Treasury said the Biden administration’s proposal to strengthen tax compliance includes a requirement for transfers of at least $10,000 of cryptocurrency to be reported to the Internal Revenue Service.“As with cash transactions, businesses that receive cryptoassets with a fair-market value of more than $10,000 would also be reported on,” the Treasury Department said in a report on tax-enforcement proposals released Thursday.The Treasury said that comprehensive reporting is necessary “to minimize the incentives and opportunity to shift income out of the new information reporting regime.” Itnotedthat cryptocurrency is a small share of current business transactions.The IRS in 2020 added a line about cryptocurrency on the Form 1040, the individual tax return, in an effort to gain more visibility into virtual currency transactions.President Joe Biden’s administration is also calling for banks to report on account flows to help boost tax-payment compliance.“Cryptocurrency already poses a significant detection problem by facilitating illegal activity broadly including tax evasion,” the Treasury said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162130648,"gmtCreate":1624039458284,"gmtModify":1703827463061,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162130648","repostId":"2142139223","repostType":2,"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166018087,"gmtCreate":1623985302249,"gmtModify":1703825657787,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166018087","repostId":"2144740494","repostType":2,"repost":{"id":"2144740494","pubTimestamp":1623956340,"share":"https://www.laohu8.com/m/news/2144740494?lang=&edition=full","pubTime":"2021-06-18 02:59","market":"us","language":"en","title":"Virgin Galactic Holdings, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2144740494","media":"GlobeNewswire","summary":"Investors with losses are encouraged to contact the firm before July 27, 2021; click here to submit ","content":"<html><body><p><em>Investors with losses are encouraged to contact the firm before </em><strong><em>July 27, 2021</em></strong><em>; click </em><em><u>here</u></em><em> to submit trade information</em><strong></strong></p>\n<p>LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- <u>The Portnoy Law Firm</u> advises investors that a class action lawsuit has been filed on behalf of <strong>Virgin Galactic Holdings, Inc. </strong>(NYSE: SPCE) investors that acquired shares between October 26, 2019 and April 30, 2021. Investors have until <strong>July 27, 2021</strong> to seek an active role in this litigation.</p>\n<p>Investors are encouraged to contact attorney <u>Lesley F. Portnoy</u><u>,</u> to determine eligibility to participate in this action, by phone 310-692-8883 or <u>email</u>, or <u>click here</u> to join the case.</p>\n<p>It is alleged in this lawsuit that, throughout the Class Period, Virgin made misleading and false statements and failed to disclose that: (i) SCH’s warrants were required to be treated as liabilities, as opposed to equities, for accounting purposes; (ii) Virgin Galactic’s disclosure controls and procedures and internal control over financial reporting were deficient; (iii) consequently, Virgin Galactic improperly accounted for SCH warrants that were outstanding at the time of the business combination; and (iv) Virgin Galactic’s public statements were materially false and misleading at all relevant times, as a result.</p>\n<p>A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than <strong>July 27, 2021</strong>.</p>\n<p>Please visit our <u>website</u> to review more information and submit your transaction information.</p>\n<p>The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.</p>\n<p>Lesley F. Portnoy, Esq.<br/>Admitted CA and NY Bar<br/><u>lesley@portnoylaw.com</u><br/>310-692-8883<br/>www.portnoylaw.com</p>\n<p>Attorney Advertising</p>\n<br/>\n<img height=\"1\" src=\"https://ml.globenewswire.com/release/track/004b3083-549c-4a92-8364-24529a6e4e75\" width=\"1\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Virgin Galactic Holdings, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVirgin Galactic Holdings, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 02:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/virgin-galactic-holdings-inc-investors-185900824.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors with losses are encouraged to contact the firm before July 27, 2021; click here to submit trade information\nLOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ...</p>\n\n<a href=\"https://finance.yahoo.com/news/virgin-galactic-holdings-inc-investors-185900824.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/vZ3UH2EdxMs0O0SoJBfirg--~B/aD01NDA7dz01NjE7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/8w4T638Ybn7xmMD4.S8Mow--~B/aD01NDA7dz01NjE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d51fcd01d577c5992de05b0b83851156","relate_stocks":{"CRCT":"Cricut, Inc.","TERN":"Terns Pharmaceuticals, Inc.","SPCE":"维珍银河"},"source_url":"https://finance.yahoo.com/news/virgin-galactic-holdings-inc-investors-185900824.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2144740494","content_text":"Investors with losses are encouraged to contact the firm before July 27, 2021; click here to submit trade information\nLOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Virgin Galactic Holdings, Inc. (NYSE: SPCE) investors that acquired shares between October 26, 2019 and April 30, 2021. Investors have until July 27, 2021 to seek an active role in this litigation.\nInvestors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case.\nIt is alleged in this lawsuit that, throughout the Class Period, Virgin made misleading and false statements and failed to disclose that: (i) SCH’s warrants were required to be treated as liabilities, as opposed to equities, for accounting purposes; (ii) Virgin Galactic’s disclosure controls and procedures and internal control over financial reporting were deficient; (iii) consequently, Virgin Galactic improperly accounted for SCH warrants that were outstanding at the time of the business combination; and (iv) Virgin Galactic’s public statements were materially false and misleading at all relevant times, as a result.\nA class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 27, 2021.\nPlease visit our website to review more information and submit your transaction information.\nThe Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.\nLesley F. Portnoy, Esq.Admitted CA and NY Barlesley@portnoylaw.com310-692-8883www.portnoylaw.com\nAttorney Advertising","news_type":1},"isVote":1,"tweetType":1,"viewCount":98,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166036324,"gmtCreate":1623985153668,"gmtModify":1703825644442,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Sold too early","listText":"Sold too early","text":"Sold too early","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166036324","repostId":"2144710151","repostType":2,"repost":{"id":"2144710151","pubTimestamp":1623900336,"share":"https://www.laohu8.com/m/news/2144710151?lang=&edition=full","pubTime":"2021-06-17 11:25","market":"us","language":"en","title":"The Opportunity In XPeng Inc. (NYSE:XPEV) And The Risks From The Big Picture","url":"https://stock-news.laohu8.com/highlight/detail?id=2144710151","media":"Simply Wall St.","summary":"This article was originally published on Simply Wall St News.\nShareholders of XPeng Inc. ( NYSE:XPEV","content":"<html><body><p><em>This article was originally published on Simply Wall St News.</em></p>\n<p>Shareholders of <strong>XPeng Inc.</strong> ( NYSE:XPEV ) will be pleased this month, given that the stock price is up 74% to US$41.03 following its latest first-quarter results.</p>\n<p>This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business.</p>\n<p>The company is powering ahead and has posted strong vehicle delivery results. Xpeng delivered a total of 5,686 Smart EVs in May 2021, representing a 483% increase year-over-year, and a 10% increase over last month.</p>\n<p>The May deliveries consisted of 3,797 P7s, the Company’s sports smart sedan, and 1,889 G3s, its smart compact SUV.</p>\n<p><strong>Earnings And Future Estimates</strong></p>\n<p>We also gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.</p>\n<p>View our latest analysis for XPeng</p>\n<p><img src=\"https://s1.yimg.com/uu/api/res/1.2/qyEJJqIrXMp5JxcGM0x3LA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/simply_wall_st__316/de630e143f9bfd3e2bfef1079cf05ec9\"/> <em>NYSE:XPEV Earnings and Revenue Growth June 2021</em></p>\n<p>Taking into account the latest results, the current consensus from XPeng's 13 analysts is for revenues of CN¥14.4b in 2021, which would reflect a sizable 72% increase in its sales over the past 12 months.</p>\n<p>The consensus price target was unchanged at US$47.10 (bullish at US$69.73, bearish at US$32.21) suggesting that the business is executing in line with estimates.</p>\n<p>Another way we can view these estimates is in the context of the bigger picture.</p>\n<p>It's pretty clear that there is an expectation that XPeng's revenue growth will slow down substantially, with revenues to the end of 2021 expected to display 106% growth on an annualized basis. This is compared to a historical growth rate of 296% over the past year.</p>\n<p>By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 22% annually. XPeng is expected to grow faster than the wider industry because it is in its high growth phase where the product will be tested by the market.</p>\n<p>Although some analysts are estimating a break into profitability around 2025, it is important to note that a capital intensive business such as auto manufacturing should not aspire for early profitability and make sure to heavily reinvest into their production capacities.</p>\n<h3>Thinking Macro</h3>\n<p>Investors should also compare the number of new car manufacturing companies popping up in the last few years with the overall industry trends. The graph below demonstrates the cyclicality of automobiles.</p>\n<p><img src=\"https://s.yimg.com/uu/api/res/1.2/trdPDJg_5DCsbTskRtLEDg--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/simply_wall_st__316/a1be4f3e65c3968bcecc4b43f4ca195a\"/> [ <em>U.S. Bureau of Economic Analysis, Light Weight Vehicle Sales: Autos and Light Trucks [ALTSALES], retrieved from FRED, Federal Reserve Bank of St. Louis;</em> ](https://fred.stlouisfed.org/series/ALTSALES, June 9, 2021.)</p>\n<p>Investors can be more comfortable with their approach if they answer some following questions:</p>\n<ul>\n<li>Is this industry going to grow in the next 3 to 5 years?</li>\n<li>Are sales going to be supported by consumers switching from fuel to electrical vehicles?</li>\n<li>Are economic pressures going to prompt consumers to buy used vehicles, lease, or engage in more car sharing schemes?</li>\n<li>What are some positive catalysts for this industry: government subsidies &amp; target adoption rates, adaptation of EVs, innovations in energy, etc?</li>\n<li>What are some possible negative catalysts: Car sharing and car renting platforms, improved public transportation schemes in urban areas, cultural shifts in car ownership preferences, inflation of new and used vehicle prices, etc?</li>\n<li>Will smaller auto manufacturers be eaten up by the established giants, or will they have a way to differentiate and survive on the market?</li>\n</ul>\n<p>As you may notice, the success of such a company lies both in the internal operations and external industry factors.</p>\n<h3>The Bottom Line</h3>\n<p>A potential investment like XPeng should be weighed both from the internal and external angle.</p>\n<p>Analyst projections and current performance put this company on the high growth path.</p>\n<p>However, investors need a good plan of how to approach a company like this. A few examples of dealing with the risks of a young company in a new business include:</p>\n<ul>\n<li>Consider a group of similar companies in the same industry. If you feel that there are good prospects in a product/industry, you may be safer spreading your investment across more companies and avoid a failed single stock.</li>\n<li>Think about industry capacity: weight the fear of missing out in a stock versus the price of entry in a market. If you feel fundamentals do not justify the current price within an industry, then you might prefer to wait for a better entry price.Consider the other side. If this company loses, who will grab the transportation market share? EV competitors, ride-sharing platforms, used car dealerships, leasing companies, the old and established companies?</li>\n</ul>\n<p>With that in mind, we wouldn't be too quick to come to a conclusion on XPeng. Long-term earnings power is much more important than next year's profits. We have estimates — from multiple XPeng analysts — going out to 2025, and you can see them free on our platform here.</p>\n<p>Take a look at the  <strong>2 warning signs for XPeng</strong>  that you need to be mindful of.</p>\n<p><i>Simply Wall St analyst Goran Damchevski and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.</i></p>\n<p><strong>Have feedback on this article? Concerned about the content? Get in touch with us directly.</strong><em> Alternatively, email editorial-team@simplywallst.com</em></p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Opportunity In XPeng Inc. (NYSE:XPEV) And The Risks From The Big Picture</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Opportunity In XPeng Inc. (NYSE:XPEV) And The Risks From The Big Picture\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 11:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/opportunity-xpeng-inc-nyse-xpev-032536476.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This article was originally published on Simply Wall St News.\nShareholders of XPeng Inc. ( NYSE:XPEV ) will be pleased this month, given that the stock price is up 74% to US$41.03 following its latest...</p>\n\n<a href=\"https://finance.yahoo.com/news/opportunity-xpeng-inc-nyse-xpev-032536476.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/_9zzNmZ6qsbXfP5hpVOUYw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/N4lVz32CwOX7hfOKNOczsA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7665404e4784395f2fabaf0da7c7079d","relate_stocks":{"XPEV":"小鹏汽车","CRCT":"Cricut, Inc.","TERN":"Terns Pharmaceuticals, Inc."},"source_url":"https://finance.yahoo.com/news/opportunity-xpeng-inc-nyse-xpev-032536476.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2144710151","content_text":"This article was originally published on Simply Wall St News.\nShareholders of XPeng Inc. ( NYSE:XPEV ) will be pleased this month, given that the stock price is up 74% to US$41.03 following its latest first-quarter results.\nThis is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business.\nThe company is powering ahead and has posted strong vehicle delivery results. Xpeng delivered a total of 5,686 Smart EVs in May 2021, representing a 483% increase year-over-year, and a 10% increase over last month.\nThe May deliveries consisted of 3,797 P7s, the Company’s sports smart sedan, and 1,889 G3s, its smart compact SUV.\nEarnings And Future Estimates\nWe also gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.\nView our latest analysis for XPeng\n NYSE:XPEV Earnings and Revenue Growth June 2021\nTaking into account the latest results, the current consensus from XPeng's 13 analysts is for revenues of CN¥14.4b in 2021, which would reflect a sizable 72% increase in its sales over the past 12 months.\nThe consensus price target was unchanged at US$47.10 (bullish at US$69.73, bearish at US$32.21) suggesting that the business is executing in line with estimates.\nAnother way we can view these estimates is in the context of the bigger picture.\nIt's pretty clear that there is an expectation that XPeng's revenue growth will slow down substantially, with revenues to the end of 2021 expected to display 106% growth on an annualized basis. This is compared to a historical growth rate of 296% over the past year.\nBy way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 22% annually. XPeng is expected to grow faster than the wider industry because it is in its high growth phase where the product will be tested by the market.\nAlthough some analysts are estimating a break into profitability around 2025, it is important to note that a capital intensive business such as auto manufacturing should not aspire for early profitability and make sure to heavily reinvest into their production capacities.\nThinking Macro\nInvestors should also compare the number of new car manufacturing companies popping up in the last few years with the overall industry trends. The graph below demonstrates the cyclicality of automobiles.\n [ U.S. Bureau of Economic Analysis, Light Weight Vehicle Sales: Autos and Light Trucks [ALTSALES], retrieved from FRED, Federal Reserve Bank of St. Louis; ](https://fred.stlouisfed.org/series/ALTSALES, June 9, 2021.)\nInvestors can be more comfortable with their approach if they answer some following questions:\n\nIs this industry going to grow in the next 3 to 5 years?\nAre sales going to be supported by consumers switching from fuel to electrical vehicles?\nAre economic pressures going to prompt consumers to buy used vehicles, lease, or engage in more car sharing schemes?\nWhat are some positive catalysts for this industry: government subsidies & target adoption rates, adaptation of EVs, innovations in energy, etc?\nWhat are some possible negative catalysts: Car sharing and car renting platforms, improved public transportation schemes in urban areas, cultural shifts in car ownership preferences, inflation of new and used vehicle prices, etc?\nWill smaller auto manufacturers be eaten up by the established giants, or will they have a way to differentiate and survive on the market?\n\nAs you may notice, the success of such a company lies both in the internal operations and external industry factors.\nThe Bottom Line\nA potential investment like XPeng should be weighed both from the internal and external angle.\nAnalyst projections and current performance put this company on the high growth path.\nHowever, investors need a good plan of how to approach a company like this. A few examples of dealing with the risks of a young company in a new business include:\n\nConsider a group of similar companies in the same industry. If you feel that there are good prospects in a product/industry, you may be safer spreading your investment across more companies and avoid a failed single stock.\nThink about industry capacity: weight the fear of missing out in a stock versus the price of entry in a market. If you feel fundamentals do not justify the current price within an industry, then you might prefer to wait for a better entry price.Consider the other side. If this company loses, who will grab the transportation market share? EV competitors, ride-sharing platforms, used car dealerships, leasing companies, the old and established companies?\n\nWith that in mind, we wouldn't be too quick to come to a conclusion on XPeng. Long-term earnings power is much more important than next year's profits. We have estimates — from multiple XPeng analysts — going out to 2025, and you can see them free on our platform here.\nTake a look at the  2 warning signs for XPeng  that you need to be mindful of.\nSimply Wall St analyst Goran Damchevski and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166031143,"gmtCreate":1623985130782,"gmtModify":1703825641998,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Crazy news","listText":"Crazy news","text":"Crazy news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166031143","repostId":"2144260237","repostType":2,"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163808078,"gmtCreate":1623865851194,"gmtModify":1703822008036,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163808078","repostId":"2143867759","repostType":2,"isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163801508,"gmtCreate":1623865839004,"gmtModify":1703822007873,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Is that truw","listText":"Is that truw","text":"Is that truw","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163801508","repostId":"1181966550","repostType":2,"isVote":1,"tweetType":1,"viewCount":178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":387757558,"gmtCreate":1613789790174,"gmtModify":1704885052468,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/387757558","repostId":"1179306002","repostType":4,"repost":{"id":"1179306002","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613727528,"share":"https://www.laohu8.com/m/news/1179306002?lang=&edition=full","pubTime":"2021-02-19 17:38","market":"us","language":"en","title":"Big tech-led equity inflows fuelling 'mother-of-all asset bubbles': BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=1179306002","media":"Reuters","summary":"LONDON (Reuters) - A record rush to big technology stocks saw equity funds bagging $27.8 billion inf","content":"<p>LONDON (Reuters) - A record rush to big technology stocks saw equity funds bagging $27.8 billion inflows last week with the ongoing ultra-easy monetary policy creating the “mother-of-all asset bubbles”, BofA said on Friday.</p><p>Global market capitalisation has risen $50 trillion, or $6.2 billion per hour, since last March, almost ten times faster than the pace seen in the immediate aftermath of the 2008 global financial crisis, the U.S. investment bank said.</p><p>Big tech attracted a record $19 billion inflows in the last six weeks. Bond funds took in $12.6 billion in the week to Wednesday, BofA’s flow data showed.</p><p>Outflows of just $300 million marked the largest drawdown in emerging markets debt since July 2020, while emerging market stock funds saw $5.3 billion inflows.</p><p>Meanwhile, surging inflation expectations has led to real assets outperforming financial assets so far in 2021, prompting investors to pour $1.2 billion into Treasury inflation-protected securities (TIPS).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Big tech-led equity inflows fuelling 'mother-of-all asset bubbles': BofA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBig tech-led equity inflows fuelling 'mother-of-all asset bubbles': BofA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-19 17:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON (Reuters) - A record rush to big technology stocks saw equity funds bagging $27.8 billion inflows last week with the ongoing ultra-easy monetary policy creating the “mother-of-all asset bubbles”, BofA said on Friday.</p><p>Global market capitalisation has risen $50 trillion, or $6.2 billion per hour, since last March, almost ten times faster than the pace seen in the immediate aftermath of the 2008 global financial crisis, the U.S. investment bank said.</p><p>Big tech attracted a record $19 billion inflows in the last six weeks. Bond funds took in $12.6 billion in the week to Wednesday, BofA’s flow data showed.</p><p>Outflows of just $300 million marked the largest drawdown in emerging markets debt since July 2020, while emerging market stock funds saw $5.3 billion inflows.</p><p>Meanwhile, surging inflation expectations has led to real assets outperforming financial assets so far in 2021, prompting investors to pour $1.2 billion into Treasury inflation-protected securities (TIPS).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179306002","content_text":"LONDON (Reuters) - A record rush to big technology stocks saw equity funds bagging $27.8 billion inflows last week with the ongoing ultra-easy monetary policy creating the “mother-of-all asset bubbles”, BofA said on Friday.Global market capitalisation has risen $50 trillion, or $6.2 billion per hour, since last March, almost ten times faster than the pace seen in the immediate aftermath of the 2008 global financial crisis, the U.S. investment bank said.Big tech attracted a record $19 billion inflows in the last six weeks. Bond funds took in $12.6 billion in the week to Wednesday, BofA’s flow data showed.Outflows of just $300 million marked the largest drawdown in emerging markets debt since July 2020, while emerging market stock funds saw $5.3 billion inflows.Meanwhile, surging inflation expectations has led to real assets outperforming financial assets so far in 2021, prompting investors to pour $1.2 billion into Treasury inflation-protected securities (TIPS).","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186032018,"gmtCreate":1623464705434,"gmtModify":1704204361627,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hey guys","listText":"Hey guys","text":"Hey guys","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/186032018","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://www.laohu8.com/m/news/2142204074?lang=&edition=full","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","UPRO":"三倍做多标普500ETF","SDOW":"道指三倍做空ETF-ProShares","QID":"纳指两倍做空ETF","IVV":"标普500指数ETF","SDS":"两倍做空标普500ETF","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF","SH":"标普500反向ETF","SSO":"两倍做多标普500ETF","QLD":"纳指两倍做多ETF",".DJI":"道琼斯","DDM":"道指两倍做多ETF","OEF":"标普100指数ETF-iShares","QQQ":"纳指100ETF",".IXIC":"NASDAQ Composite","SQQQ":"纳指三倍做空ETF","DOG":"道指反向ETF",".SPX":"S&P 500 Index","OEX":"标普100","SPXU":"三倍做空标普500ETF","DXD":"道指两倍做空ETF","DJX":"1/100道琼斯","UDOW":"道指三倍做多ETF-ProShares"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323040120,"gmtCreate":1615292776260,"gmtModify":1704780696523,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>&nbsp;ok i trust you","listText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>&nbsp;ok i trust you","text":"$Luokung Technology Corp(LKCO)$ ok i trust you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323040120","isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120326803,"gmtCreate":1624303348102,"gmtModify":1703832930486,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Buyy","listText":"Buyy","text":"Buyy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/120326803","repostId":"2145084835","repostType":2,"repost":{"id":"2145084835","pubTimestamp":1624280460,"share":"https://www.laohu8.com/m/news/2145084835?lang=&edition=full","pubTime":"2021-06-21 21:01","market":"us","language":"en","title":"5 Ultra-Popular Stocks Wall Street Views as Overvalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2145084835","media":"Motley Fool","summary":"If analysts are correct, these high-flying stocks will fizzle out over the next year.","content":"<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark <b>S&amp;P 500</b> since 1980, including dividends, is north of 11%.</p>\n<p>Not surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to <b>FactSet</b>, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.</p>\n<p>Based on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.</p>\n<p><img src=\"https://static.tigerbbs.com/b04ade705354c4825038c4dfcd0187d9\" tg-width=\"700\" tg-height=\"500\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Palantir Technologies: Implied downside of 12%</h3>\n<p>Since its direct listing in late September 2020, data-mining company <b>Palantir Technologies</b> (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's <a href=\"https://laohu8.com/S/AONE\">one</a>-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.</p>\n<p>The likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.</p>\n<p>Another possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.</p>\n<p>Over the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.</p>\n<p><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Moderna: Implied downside of 11%</h3>\n<p>Biotech stock <b>Moderna</b> (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.</p>\n<p>Why the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.</p>\n<p>The other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.</p>\n<p>Based solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.</p>\n<p><img src=\"https://static.tigerbbs.com/07841e6a8173146a0fbfddf95a0f1ccb\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>GameStop: Implied downside of 71%</h3>\n<p>This will probably come as a shock to no one, but Reddit favorite <b>GameStop</b> (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it <i>still</i> implies up to 71% downside over the next year.</p>\n<p>The biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.</p>\n<p>Although the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.</p>\n<p>With sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.</p>\n<p><img src=\"https://static.tigerbbs.com/c7ff785aa0040a5565d474390f58b47a\" tg-width=\"700\" tg-height=\"457\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Ocugen: Implied downside of 18%</h3>\n<p>Volatile clinical-stage biotech stock <b>Ocugen</b> (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.</p>\n<p>Arguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.</p>\n<p>What's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.</p>\n<p>Though it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.</p>\n<p><img src=\"https://static.tigerbbs.com/91f6037829ea3fb0ae1cae0b95d8d11e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>NVIDIA: Implied downside of 3%</h3>\n<p>Don't adjust your computer, laptop, or smartphone screens -- that really says <b>NVIDIA</b> (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.</p>\n<p>One reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.</p>\n<p>Perhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.</p>\n<p>For what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks Wall Street Views as Overvalued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks Wall Street Views as Overvalued\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 21:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","PLTR":"Palantir Technologies Inc.","GME":"游戏驿站","OCGN":"Ocugen","MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/06/21/5-ultra-popular-stocks-wall-street-view-overvalued/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145084835","content_text":"Generally speaking, it pays to be bullish on Wall Street. Despite navigating its way through Black Monday in 1987, the dot-com bubble, the Great Recession, and more recently the coronavirus crash, the average annual total return for the benchmark S&P 500 since 1980, including dividends, is north of 11%.\nNot surprisingly, we see this optimism readily apparent in Wall Street's ratings on stocks. According to FactSet, more than half of all stocks carry a consensus buy rating, 38% have the equivalent of a hold rating, and just 7% are rated as sells. Yet, history shows that far more than 7% of stocks will eventually head lower.\nBased on Wall Street's consensus price targets, the following five ultra-popular stocks are all expected to lose value over the coming 12 months.\n\nImage source: Getty Images.\nPalantir Technologies: Implied downside of 12%\nSince its direct listing in late September 2020, data-mining company Palantir Technologies (NYSE:PLTR) has been a favorite among growth and retail investors. But if Wall Street's one-year consensus price target proves accurate, Palantir will head in reverse by up to 12%.\nThe likeliest reason Wall Street is tempering expectations on Palantir is valuation. Specifically, Palantir ended June 17 with a market cap of nearly $48 billion, but is on track to bring in perhaps $1.5 billion in full-year sales in 2021. That's a multiple of about 32 times sales. Even if Palantir continues to grow its top-line at 30% annually, it could take years for this price-to-sales multiple to come down to anywhere close to the average for cloud stocks.\nAnother possible concern is the growth potential for its government-focused Gotham platform. Big government contract wins in the U.S. have been primarily responsible for Palantir's exceptional growth rate. However, there remains an outside chance that President Joe Biden may curb funding to some of the federal agencies that employ Palantir's services.\nOver the long run, I'm optimistic and believe Palantir's platform is unlike anything else available. But tempering near-term expectations given its valuation premium may be warranted.\n\nImage source: Getty Images.\nModerna: Implied downside of 11%\nBiotech stock Moderna (NASDAQ:MRNA) is arguably the biggest beneficiary of the coronavirus disease 2019 (COVID-19) pandemic. It's one of only three drugmakers to currently have their COVID-19 vaccine approved on an emergency-use authorization (EUA) basis in the United States. But if Wall Street's consensus 12-month price target is correct, it's stock is also on its way to a double-digit decline.\nWhy the lack of love from Wall Street? The answer looks to be analysts looking to the future. While Moderna's COVID-19 vaccine is a mainstay in the U.S., and it's likely to play a clear role in other markets, time might prove the company's enemy. Over time, new vaccines are expected to come onto the scene, which'll eat away at Moderna's potential pool of patients.\nThe other worry is that no one is exactly certain how long COVID-19 vaccine immunity will last. If it's a year, Moderna is unlikely to be the only drugmaker supplying booster shots. Meanwhile, if it's longer than a year, it means reduced sales opportunities for the company.\nBased solely on Wall Street's earnings per share consensus in 2021 and 2022, Moderna appears reasonably priced. But with the company staring down a potentially significant haircut in revenue next year as new drugmakers enter the space, caution is advised.\n\nImage source: Getty Images.\nGameStop: Implied downside of 71%\nThis will probably come as a shock to no one, but Reddit favorite GameStop (NYSE:GME) is fully expected to fall flat on its face. Even though Wall Street's consensus price target for the company has quintupled in recent months, it still implies up to 71% downside over the next year.\nThe biggest issue for GameStop is that its valuation has completely detached from its underlying fundamentals. While it's not uncommon for stocks to trade on emotion for short periods of time, operating performance is what always dictates the long-term movement in the share price of a stock. When it comes to operating performance, GameStop has been a dud.\nAlthough the company's first-quarter fiscal results highlighted a 25% net sales increase from the prior-year period, total sales for the company have been falling precipitously for years. That's because video game retailer GameStop recognized the shift to digital gaming too late, and it's now stuck with its massive portfolio of brick-and-mortar gaming stores. Even though e-commerce sales have been a bright spot for the company, slashing costs and closing stores remains its No. 1 priority.\nWith sufficient cash, bankruptcy isn't a concern for GameStop. But without any true top-line growth and the company still losing money, it's an impossible sell at its current price tag.\n\nImage source: Getty Images.\nOcugen: Implied downside of 18%\nVolatile clinical-stage biotech stock Ocugen (NASDAQ:OCGN) may also be in for an unpleasant next 12 months. The company behind an experimental COVID-19 vaccine (Covaxin) and a trio of internally developed eye-blindness candidates is expected to shed 18% of its value, if Wall Street's consensus price target is correct.\nArguably the biggest issue for Ocugen is the clinical update the company issued on June 10 concerning Covaxin. Even though partner Bharat Biotech led a large clinical study in India that yielded an overall efficacy of 78%, along with 100% efficacy in preventing severe forms of COVID-19, Ocugen announced on June 10 that it would forgo seeking an EUA in the U.S. and would instead file for a biologics license application. In other words, Ocugen's path to a quick emergency approval in the U.S. just flew out the window.\nWhat's more, the U.S. Food and Drug Administration's requested additional information and data on Covaxin. This is a fancy of saying that Ocugen will very likely have to run a clinical study in the U.S. prior to submitting Covaxin for approval. That means added costs and an even longer wait before Ocugen has a chance to penetrate the lucrative U.S. market.\nThough it's impossible to predict how long COVID-19 vaccine immunity will last, Ocugen's chances of being a significant player in the U.S. COVID-19 vaccine space are dwindling.\n\nImage source: Getty Images.\nNVIDIA: Implied downside of 3%\nDon't adjust your computer, laptop, or smartphone screens -- that really says NVIDIA (NASDAQ:NVDA). Following its incredible run higher (NVIDIA has doubled over the past year), graphics processing unit giant NVIDIA closed 3% above Wall Street's consensus price target, as of June 17.\nOne reason for tempered expectations at this point has to be valuation. Even with NVIDIA crushing expectations and seeing strong PC gaming demand, sales growth is expected to slow from an estimated 49% in fiscal 2022 to a high single digit percentage in each of the next two fiscal years. In fact, the company closed at nearly 20 times projected sales for the current fiscal year. That's a bit optimistic given an expected sales growth slowdown.\nPerhaps the other reason Wall Street expects NVIDIA to go sideways is the company's cryptocurrency mining chip segment. While sales of crypto chips could hit $400 million in the current quarter, demand is entirely dependent on the hype surrounding digital currencies and the favorability of technical charts. Crypto is just as well known for its long bear markets as it is for the big gains it's delivered over the past decade. If another lull strikes, a fast-growing ancillary segment for NVIDA could easily become a drag.\nFor what it's worth, I see no fundamental reasons to sell NVIDIA if you're already a long-term shareholder. But if you're on the outside looking in, I don't exactly see $746 as an attractive entry point, either.","news_type":1},"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323049006,"gmtCreate":1615292859205,"gmtModify":1704780697169,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nicw","listText":"Nicw","text":"Nicw","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/323049006","repostId":"1115541540","repostType":4,"repost":{"id":"1115541540","pubTimestamp":1615290562,"share":"https://www.laohu8.com/m/news/1115541540?lang=&edition=full","pubTime":"2021-03-09 19:49","market":"us","language":"en","title":"ARK Innovation Rebounds As Cathie Wood Stands Firm on Tech Bets; Tesla Surges","url":"https://stock-news.laohu8.com/highlight/detail?id=1115541540","media":"TheStreet","summary":"Cathie Wood stood in to defend her ARK Innovation ETF late Monday as losses continue to hit the tech","content":"<p>Cathie Wood stood in to defend her ARK Innovation ETF late Monday as losses continue to hit the tech-focused fund amid a broader market rotation into value stocks.</p>\n<p>ARK Innovation ETF&nbsp;(<b>ARKK</b>)&nbsp;shares rebounded sharply Tuesday star fund manager Cathie Wood stood firm in defense against the recent slump in her tech-focused holdings.</p>\n<p>Wood told CNBC late Monday that she was becoming \"more optimistic\" about her portfolios amid the ongoing tech sell-off, which has tipped the Nasdaq Composite into correction territory and hived nearly 30% from her flagship ARK Innovation fund since its February 12 closing peak.</p>\n<p>A 'broadening' of the current market rally, Wood argued, will give her both a chance to add to current positions on stocks such as Tesla&nbsp;(<b>TSLA</b>)&nbsp;and Roku&nbsp;(<b>ROKU</b>)&nbsp;at lower levels while simultaneously moving into so-called pure-play stocks whose growth trajectory is more in-line with the U.S. post-pandemic recovery.</p>\n<p>“The bull market was broadening out to incorporate value or more cyclical sectors and I thought that was going to be very good news for our strategies longer run,\" Wood said. \"The worst thing that could have happened to us what another tech and telecom bubble where the market narrowed so that only a few groups won.\"</p>\n<p>Ark Innovation ETF shares were marked 4.6% higher in pre-market trading Tuesday, indicating an opening bell price of $115.34 each, a move that would trim its month-to-date decline to around 25.5%.</p>\n<p>Tesla shares jumped 5.1% in pre-market trading to $591.52 each, while Bitcoin, another key holding in the ARK portfolio, was marked 4.7% higher at just over $54,000.00.</p>\n<p>Short interest in the fund, however, has accelerated amid the recent surge in U.S. Treasury bond yields and the corresponding pullback in tech stocks, particularly Tesla, which has lost nearly $300 billion in market value since its early January peak amid a near 30% decline in its share price.</p>\n<p>Data from S3 Partners indicates around $2.31 billion in currently being bet against the ARK Innovation ETF, a figure that represents around 19.76 million shares, or 10.8% of its outstanding float.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ARK Innovation Rebounds As Cathie Wood Stands Firm on Tech Bets; Tesla Surges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nARK Innovation Rebounds As Cathie Wood Stands Firm on Tech Bets; Tesla Surges\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-09 19:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/ark-innovation-rebounds-as-cathie-wood-stands-firm-on-tech-bets><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood stood in to defend her ARK Innovation ETF late Monday as losses continue to hit the tech-focused fund amid a broader market rotation into value stocks.\nARK Innovation ETF (ARKK) shares ...</p>\n\n<a href=\"https://www.thestreet.com/investing/ark-innovation-rebounds-as-cathie-wood-stands-firm-on-tech-bets\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","ARKK":"ARK Innovation ETF"},"source_url":"https://www.thestreet.com/investing/ark-innovation-rebounds-as-cathie-wood-stands-firm-on-tech-bets","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115541540","content_text":"Cathie Wood stood in to defend her ARK Innovation ETF late Monday as losses continue to hit the tech-focused fund amid a broader market rotation into value stocks.\nARK Innovation ETF (ARKK) shares rebounded sharply Tuesday star fund manager Cathie Wood stood firm in defense against the recent slump in her tech-focused holdings.\nWood told CNBC late Monday that she was becoming \"more optimistic\" about her portfolios amid the ongoing tech sell-off, which has tipped the Nasdaq Composite into correction territory and hived nearly 30% from her flagship ARK Innovation fund since its February 12 closing peak.\nA 'broadening' of the current market rally, Wood argued, will give her both a chance to add to current positions on stocks such as Tesla (TSLA) and Roku (ROKU) at lower levels while simultaneously moving into so-called pure-play stocks whose growth trajectory is more in-line with the U.S. post-pandemic recovery.\n“The bull market was broadening out to incorporate value or more cyclical sectors and I thought that was going to be very good news for our strategies longer run,\" Wood said. \"The worst thing that could have happened to us what another tech and telecom bubble where the market narrowed so that only a few groups won.\"\nArk Innovation ETF shares were marked 4.6% higher in pre-market trading Tuesday, indicating an opening bell price of $115.34 each, a move that would trim its month-to-date decline to around 25.5%.\nTesla shares jumped 5.1% in pre-market trading to $591.52 each, while Bitcoin, another key holding in the ARK portfolio, was marked 4.7% higher at just over $54,000.00.\nShort interest in the fund, however, has accelerated amid the recent surge in U.S. Treasury bond yields and the corresponding pullback in tech stocks, particularly Tesla, which has lost nearly $300 billion in market value since its early January peak amid a near 30% decline in its share price.\nData from S3 Partners indicates around $2.31 billion in currently being bet against the ARK Innovation ETF, a figure that represents around 19.76 million shares, or 10.8% of its outstanding float.","news_type":1},"isVote":1,"tweetType":1,"viewCount":7,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":387756863,"gmtCreate":1613789495252,"gmtModify":1704885046312,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CFAC\">$CF Finance Acquisition III Corp(CFAC)$</a>&nbsp;why the dip","listText":"<a href=\"https://laohu8.com/S/CFAC\">$CF Finance Acquisition III Corp(CFAC)$</a>&nbsp;why the dip","text":"$CF Finance Acquisition III Corp(CFAC)$ why the dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/387756863","isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186032534,"gmtCreate":1623464729628,"gmtModify":1704204356766,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186032534","repostId":"2142858202","repostType":4,"repost":{"id":"2142858202","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623453060,"share":"https://www.laohu8.com/m/news/2142858202?lang=&edition=full","pubTime":"2021-06-12 07:11","market":"hk","language":"en","title":"Don't be fooled by some of the hawkish sounds coming out of the Fed next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142858202","media":"Dow Jones","summary":"Fed will remain dovish, economists say.\n\nThere are sixteen different types of hawks found in the Uni","content":"<blockquote>\n Fed will remain dovish, economists say.\n</blockquote>\n<p>There are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.</p>\n<p>Much will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.</p>\n<p>\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.</p>\n<p>U.S. inflation has been sizzling in recent months.</p>\n<p>But the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.</p>\n<p>While inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.</p>\n<p>\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.</p>\n<p>\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.</p>\n<p>The Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.</p>\n<p>The central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.</p>\n<p><b>What will be the hawkish sounds?</b></p>\n<p>First, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.</p>\n<p>But this is only the most preliminary of steps.</p>\n<p>Instead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.</p>\n<p>It won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.</p>\n<p>To downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.</p>\n<p>Secondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.</p>\n<p>At its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.</p>\n<p>Thirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.</p>\n<p>During press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.</p>\n<p>\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.</p>\n<p>At the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.</p>\n<p>When the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.</p>\n<p>None of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.</p>\n<p>Even if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't be fooled by some of the hawkish sounds coming out of the Fed next week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't be fooled by some of the hawkish sounds coming out of the Fed next week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 07:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Fed will remain dovish, economists say.\n</blockquote>\n<p>There are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.</p>\n<p>Much will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.</p>\n<p>\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.</p>\n<p>U.S. inflation has been sizzling in recent months.</p>\n<p>But the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.</p>\n<p>While inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.</p>\n<p>\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.</p>\n<p>\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.</p>\n<p>The Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.</p>\n<p>The central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.</p>\n<p><b>What will be the hawkish sounds?</b></p>\n<p>First, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.</p>\n<p>But this is only the most preliminary of steps.</p>\n<p>Instead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.</p>\n<p>It won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.</p>\n<p>To downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.</p>\n<p>Secondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.</p>\n<p>At its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.</p>\n<p>Thirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.</p>\n<p>During press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.</p>\n<p>\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.</p>\n<p>At the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.</p>\n<p>When the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.</p>\n<p>None of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.</p>\n<p>Even if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142858202","content_text":"Fed will remain dovish, economists say.\n\nThere are sixteen different types of hawks found in the United States, according to birdwatchingh.com . While it may be tempting, it is too soon to add Federal Reserve policymakers to that list.\nMuch will be made next week out of some potentially \"hawkish\" sounds from the U.S. central bank's policy meeting, economists said, while they stressed that Fed Chairman Jerome Powell and the majority of the voting members of the interest rate setting committee remain \"doves\" and fundamentally will be sticking to their \"patient\" stance on monetary policy.\n\"They are going to be a little bit less dovish than last time,\" said Jim O'Sullivan, chief U.S. macro strategist for TD Securities.\nU.S. inflation has been sizzling in recent months.\nBut the recent decline in long-term Treasury yields allows the Fed to lean into the hawkish message, O'Sullivan said.\nWhile inflation has been surprisingly hot, the Fed \"is willing to wait\" until the fall to see how the labor market responds to the inflation spike, said Ian Shepherdson, chief economist at Pantheon Macroeconomics. Wage pressures play a key role in determining the inflation outlook.\n\"We don't know how many people will come back into the labor market, how participation will rise, and will it be enough to dampen inflationary pressures,\" Shepherdson said.\n\"In the olden days, the Fed would have raised interest rates first and worried about what was going to happen afterwards. But this is a different Fed with a different strategy and a different approach,\" he said.\nThe Fed is buying $80 billion of Treasurys and $40 billion of mortgage backed securities each month, along with keeping its benchmark interest rate close to zero, to support the economy.\nThe central bank put itself in a bit of a box in December by guiding markets that it wouldn't slow down the pace of purchases until there had been \"substantial further progress\" in its goals of full employment and stable inflation.\nWhat will be the hawkish sounds?\nFirst, the Fed will give in to the reality that talking about tapering the size of its asset purchases makes sense. This is an important shift. Since December, Powell has managed to hold off such talk.\nBut this is only the most preliminary of steps.\nInstead \"officials will talk in general straw-poll terms on what principles ought to apply,\" said Lou Crandall, chief economist at Wrightson ICAP.\nIt won't be the Fed having a structured debate on a set of options game-planned by the staff. That might happen in July, but not now.\nTo downplay the significance, the Fed won't say anything about the \"talks about tapering\" in its formal statement, next Wednesday afternoon, O'Sullivan said.\nSecondly, the Fed's dot-plot, or interest rate forecast chart, may show a shift forward for the first rate hike to come during 2023. At the moment, the Fed shows no rate hikes until 2024 at the earliest.\nAt its March meeting, seven out of 18 Fed officials saw a hike before the end of 2023, and it could be nine or ten officials at the June meeting next week.\nThirdly, the Fed will have to raise its forecast for inflation for this year. In March, the Fed penciled in a 2.2% core rate for the personal consumption expenditure index. While that may rise, the Fed won't move the core rate for 2022 much higher, a signal that it still believes the price gains seen in the last few months reflects \"largely transitory\" factors.\nDuring press conferences, Powell has said the economy is \"a long way\" from the Fed's goals and it would take \"some time\" for substantial further progress to be achieved.\n\"I wouldn't pound the table and say exactly what Powell is going to say but it is time to start getting away from that language,\" O'Sullivan of TD Securities said.\nAt the same time, the Fed has got to say that while the economy has made progress, they still need to see a lot more,\" he added.\nWhen the Fed added the \"substantial further progress\" guideline, the economy was 9.8 million jobs short of its level in February 2020. At the moment, the economy is 7.6 million jobs short.\nNone of these potentially hawkish noises will disturb the central message of Fed officials to the market -- that its benchmark interest rate will stay low next year.\nEven if the Fed starts to taper its asset purchases next January, economists think it will take months before the central bank is ready to take the next step and hike its benchmark interest rates off zero.","news_type":1},"isVote":1,"tweetType":1,"viewCount":27,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188035222,"gmtCreate":1623415637366,"gmtModify":1704202993066,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188035222","repostId":"1131879907","repostType":4,"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188039992,"gmtCreate":1623415417816,"gmtModify":1704202984772,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SPCE\">$Virgin Galactic(SPCE)$</a>&nbsp;buy now","listText":"<a href=\"https://laohu8.com/S/SPCE\">$Virgin Galactic(SPCE)$</a>&nbsp;buy now","text":"$Virgin Galactic(SPCE)$ buy now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188039992","isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321499362,"gmtCreate":1615458447456,"gmtModify":1704783017688,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NCTY\">$The9(NCTY)$</a>&nbsp;lets go btc","listText":"<a href=\"https://laohu8.com/S/NCTY\">$The9(NCTY)$</a>&nbsp;lets go btc","text":"$The9(NCTY)$ lets go btc","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/321499362","isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":361945477,"gmtCreate":1614194509899,"gmtModify":1704889398876,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CCIV\">$Churchill Capital Corp IV(CCIV)$</a>&nbsp;lucid losing to tesla","listText":"<a href=\"https://laohu8.com/S/CCIV\">$Churchill Capital Corp IV(CCIV)$</a>&nbsp;lucid losing to tesla","text":"$Churchill Capital Corp IV(CCIV)$ lucid losing to tesla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/361945477","isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3573373933442219","authorId":"3573373933442219","name":"Faker124","avatar":"https://static.tigerbbs.com/f086288818f99bec0872e59469630e5e","crmLevel":2,"crmLevelSwitch":1},"content":"If you lose, the stock is still valuable, and you see $100 at the end of the year","text":"If you lose, the stock is still valuable, and you see $100 at the end of the year","html":"If you lose, the stock is still valuable, and you see $100 at the end of the year"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166031143,"gmtCreate":1623985130782,"gmtModify":1703825641998,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Crazy news","listText":"Crazy news","text":"Crazy news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166031143","repostId":"2144260237","repostType":2,"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186034336,"gmtCreate":1623464791225,"gmtModify":1704204358377,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MOXC\">$Moxian(MOXC)$</a>ups","listText":"<a href=\"https://laohu8.com/S/MOXC\">$Moxian(MOXC)$</a>ups","text":"$Moxian(MOXC)$ups","images":[{"img":"https://static.tigerbbs.com/40456ce3abe785bc2eab8692c067bcd2","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186034336","isVote":1,"tweetType":1,"viewCount":59,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":186035318,"gmtCreate":1623464751634,"gmtModify":1704204357087,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MOXC\">$Moxian(MOXC)$</a>&nbsp;buy?&nbsp;","listText":"<a href=\"https://laohu8.com/S/MOXC\">$Moxian(MOXC)$</a>&nbsp;buy?&nbsp;","text":"$Moxian(MOXC)$ buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186035318","isVote":1,"tweetType":1,"viewCount":23,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188871146,"gmtCreate":1623429957085,"gmtModify":1704203625860,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Booo","listText":"Booo","text":"Booo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/188871146","repostId":"2142206311","repostType":4,"repost":{"id":"2142206311","pubTimestamp":1623426552,"share":"https://www.laohu8.com/m/news/2142206311?lang=&edition=full","pubTime":"2021-06-11 23:49","market":"us","language":"en","title":"COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart","url":"https://stock-news.laohu8.com/highlight/detail?id=2142206311","media":"Zacks","summary":"The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention  stated that it has observed increased cases of heart inflammation in adolescents and younger adults, especially aged 12 to 24, following inoculation with authorized mRNA-based COVID-19 vaccines from Moderna MRNA, and Pfizer PFE/BioNTech BNTX.Several hundreds of cases of myocarditis and pericarditis, both conditions of heart inflammation, were reported to the U.S. government’s VAERS  following dose 1 of any mR","content":"<p>The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention (CDC) stated that it has observed increased cases of heart inflammation in adolescents and younger adults, especially aged 12 to 24, following inoculation with authorized mRNA-based COVID-19 vaccines from <b>Moderna</b> MRNA, and <b>Pfizer</b> PFE/<b>BioNTech</b> BNTX.</p><p>Several hundreds of cases of myocarditis and pericarditis, both conditions of heart inflammation, were reported to the U.S. government’s VAERS (Vaccine Adverse Event Reporting System) following dose 1 of any mRNA-based vaccine in the last two months. Please note that VAERS is a national early warning system to detect possible safety problems in U.S. licensed vaccines. The number of cases increased further after the second dose of these vaccines. Moreover, the cases occurred in higher number of younger patients following dose 2 compared to dose 1. The CDC stated that similar inflammation cases were not reported following vaccination with <b>J&amp;J</b>’s JNJ adenovirus-based COVID-19 vaccine.</p><h3>Israeli Alarm</h3><p>Per a Reuters report, the Israel’s Health Ministry raised the alarm when it reported a likely link of heart inflammation in young men vaccinated with Pfizer’s BNT162b earlier this month. Following this report, the CDC and health regulators in other countries started investigating such cases.</p><p>Although the number of reported cases is small compared to total inoculations with mRNA vaccines, they were higher than expected in the younger age groups.</p><h3>CDC Meeting</h3><p>We note that the CDC is yet to link these adverse events to mRNA vaccines and has scheduled a meeting of the Advisory Committee on Immunization Practices (ACIP) on Jun 18 to discuss and assess the heart inflammation reports. Moreover, the government authority has recommended continuation of vaccination for everyone of age 12 or older given the risk of COVID-19 illness and related complications.</p><p>However, we note that the CDC report also stated that more than 50% of heart inflammation cases were reported in the age group of 12-24 that has received only 8.8% of vaccine doses. This suggests that any adverse outcome from the ACIP meeting scheduled next week can hamper vaccination with mRNA vaccines in the adolescent patient group, and hurt prospects of these vaccine developers. However, the percentage of inflammation cases suggests that the risk from these vaccines is significantly lower than their benefits. A CDC study claims that these vaccines are 91% effective. Moreover, most patients facing inflammation issues quickly felt better following medication and rest.</p><h3>mRNA Vaccine Updates</h3><p>We remind investors that Pfizer/BioNTech’s COVID-19 vaccine received authorization for emergency use in adolescents last month from the FDA. Moderna filed for a similar authorization in the United States, Europe and Canada earlier this month.</p><p>Meanwhile, Pfizer and BioNTech have pledged two billion doses of their COVID-19 vaccines to ensure equitable access to their vaccines globally. As part of the pledge, the company plans to supply 200 million doses in 2021 and 300 million doses in the first half of 2022 to the U.S. government at not-for-profit price. The government will donate these doses to low- and lower middle-income countries and organizations that support them.</p><p>While Moderna and Pfizer carry a Zacks Rank #3 (Hold), BioNTech sports a Zacks Rank of 1 (Strong Buy). </p><p>Pfizer,&nbsp;Moderna&nbsp;fell&nbsp;over&nbsp;1%&nbsp;in&nbsp;morning&nbsp;trading.</p><p><img src=\"https://static.tigerbbs.com/4abafe1ebf6b0259e6f305a5483d4a2a\" tg-width=\"700\" tg-height=\"584\"><img src=\"https://static.tigerbbs.com/16bd6a310a9f80f7ecaf40c96b582198\" tg-width=\"700\" tg-height=\"584\"></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCOVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 23:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/covid-19-jabs-pfizer-moderna-124412703.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention (CDC) stated that it has observed increased cases of heart inflammation in adolescents and younger adults, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/covid-19-jabs-pfizer-moderna-124412703.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/i.kaShYr9WLQwJ3VXlE4CA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/aNEP4MqN0KfFI8mDHT.6JQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0bba00e006cf8b1987f4ca39d28c5938","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/covid-19-jabs-pfizer-moderna-124412703.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142206311","content_text":"The COVID-19 vaccine task force of the U.S. Centers for Disease Control and Prevention (CDC) stated that it has observed increased cases of heart inflammation in adolescents and younger adults, especially aged 12 to 24, following inoculation with authorized mRNA-based COVID-19 vaccines from Moderna MRNA, and Pfizer PFE/BioNTech BNTX.Several hundreds of cases of myocarditis and pericarditis, both conditions of heart inflammation, were reported to the U.S. government’s VAERS (Vaccine Adverse Event Reporting System) following dose 1 of any mRNA-based vaccine in the last two months. Please note that VAERS is a national early warning system to detect possible safety problems in U.S. licensed vaccines. The number of cases increased further after the second dose of these vaccines. Moreover, the cases occurred in higher number of younger patients following dose 2 compared to dose 1. The CDC stated that similar inflammation cases were not reported following vaccination with J&J’s JNJ adenovirus-based COVID-19 vaccine.Israeli AlarmPer a Reuters report, the Israel’s Health Ministry raised the alarm when it reported a likely link of heart inflammation in young men vaccinated with Pfizer’s BNT162b earlier this month. Following this report, the CDC and health regulators in other countries started investigating such cases.Although the number of reported cases is small compared to total inoculations with mRNA vaccines, they were higher than expected in the younger age groups.CDC MeetingWe note that the CDC is yet to link these adverse events to mRNA vaccines and has scheduled a meeting of the Advisory Committee on Immunization Practices (ACIP) on Jun 18 to discuss and assess the heart inflammation reports. Moreover, the government authority has recommended continuation of vaccination for everyone of age 12 or older given the risk of COVID-19 illness and related complications.However, we note that the CDC report also stated that more than 50% of heart inflammation cases were reported in the age group of 12-24 that has received only 8.8% of vaccine doses. This suggests that any adverse outcome from the ACIP meeting scheduled next week can hamper vaccination with mRNA vaccines in the adolescent patient group, and hurt prospects of these vaccine developers. However, the percentage of inflammation cases suggests that the risk from these vaccines is significantly lower than their benefits. A CDC study claims that these vaccines are 91% effective. Moreover, most patients facing inflammation issues quickly felt better following medication and rest.mRNA Vaccine UpdatesWe remind investors that Pfizer/BioNTech’s COVID-19 vaccine received authorization for emergency use in adolescents last month from the FDA. Moderna filed for a similar authorization in the United States, Europe and Canada earlier this month.Meanwhile, Pfizer and BioNTech have pledged two billion doses of their COVID-19 vaccines to ensure equitable access to their vaccines globally. As part of the pledge, the company plans to supply 200 million doses in 2021 and 300 million doses in the first half of 2022 to the U.S. government at not-for-profit price. The government will donate these doses to low- and lower middle-income countries and organizations that support them.While Moderna and Pfizer carry a Zacks Rank #3 (Hold), BioNTech sports a Zacks Rank of 1 (Strong Buy). Pfizer, Moderna fell over 1% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":25,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323968917,"gmtCreate":1615299710439,"gmtModify":1704780793984,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>&nbsp;i have faith today","listText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>&nbsp;i have faith today","text":"$Luokung Technology Corp(LKCO)$ i have faith today","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323968917","isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128468610,"gmtCreate":1624528013230,"gmtModify":1703839413460,"author":{"id":"3575086147705955","authorId":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grow","listText":"Grow","text":"Grow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128468610","repostId":"2140464395","repostType":2,"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}